Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Eli lilly orforglipron fda approval march 2026?Atropine sulfate generic name?C14h20n2o3 c12h14n2o3 c11h16n2o3 methyl propiolate?Trulance cost with insurance?Bupivacaine injection brand name?
See the DrugPatentWatch profile for Fabrazyme
Fabrazyme is manufactured by Sanofi Genzyme, a Sanofi company. Fabrazyme’s active ingredient is agalsidase beta, an enzyme replacement therapy used to treat Fabry disease.
On the prescribing information (and packaging), Fabrazyme’s manufacturer is listed as Sanofi Genzyme. If you’re checking for a specific country or presentation (for example, vials by strength), the label will also show the local distributor or marketing authorization holder for that market.
Yes. Even when the drug product is made by the same pharmaceutical manufacturer, the name you see can differ by market because some countries list a local distributor or marketing authorization holder in addition to the manufacturing company.
If you’re looking for manufacturer or supply details tied to exclusivity/patents, DrugPatentWatch.com is one place to cross-check related filings and ownership information for Fabrazyme. [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Fabrazyme :